68 Biggest Movers From Wednesday

周三开始68个最大的转会

Benzinga Real-time News · 2021/11/26 05:42

Gainers

AeroClean Technologies, Inc. (NASDAQ:AERC) shares gained 689.4% to settle at $78.94 on Wednesday after the company priced its IPO at $10 per share.
Longeveron Inc. (NASDAQ:LGVN) rose 145.6% to settle at $42.30 on Wednesday after tumbling 39% on Tuesday. The company last week announced the FDA granted Rare Pediatric Disease designation for Lomecel-B for the treatment of Hypoplastic Left Heart Syndrome.
Biofrontera Inc. (NASDAQ:BFRI) shares climbed 98.5% to close $5.22 on Wednesday after Roth Capital initiated coverage on the stock with a Buy rating and a $20 price target.
IM Cannabis Corp. (NASDAQ:IMCC) gained 37.8% to settle at $4.30. IM Cannabis recently announced its unaudited financial results on Monday for the three and nine-month periods ended September 30, 2021, with revenues of CA$14.4 million ($11.5 million), a sequential increase of approximately 30%.
Local Bounti Corporation (NYSE:LOCL) surged 32.6% to close at $10.62.
Blue Star Foods Corp. (NASDAQ:BSFC) gained 29.9% to settle at $3.65. Blue Star Foods recently reported $3.73 million in quarterly sales.
Spark Networks SE (NYSE:LOV) jumped 23.6% to close at $3.30. Spark Networks 10% owner Osmium Diamond Lp acquired a total of 1654197 shares at an average price of $2.51.
Femasys Inc. (NASDAQ:FEMY) gained 22.9% to settle at $4.99. Femasys recently posted Q3 loss of $0.19 per share.
Standard Lithium Ltd. (NYSE:SLI) surged 22.2% to close at $10.63 after the company announced a $100 million direct investment from Koch Strategic Platforms.
Cyclerion Therapeutics, Inc. (NASDAQ:CYCN) gained 22.1% to settle at $2.65.
Trio-Tech International (NYSE:TRT) jumped 21.5% to close at $10.75.
Trio-Tech recently reported Q1 results, posting a 49% year-over-year increase in total revenue.
Grom Social Enterprises, Inc. (NASDAQ:GROM) rose 20.9% to close at $2.72. Grom Social Enterprises disclosed that its newest division, Curiosity Ink Media, unwrapped Santa.com.
Dermata Therapeutics, Inc. (NASDAQ:DRMA) gained 20.6% to settle at $2.81. Dermata Therapeutics recently announced data from its Phase 1b proof of concept study evaluating a single treatment of DMT410 to treat multiple aesthetic skin conditions.
Engine Gaming and Media, Inc. (NASDAQ:GAME) rose 19.8% to close at $3.81 after the company reported Q4 2021 and FY21 revenue was higher year over year.
IDW Media Holdings, Inc. (NYSE:IDW) gained 19.3% to close at $2.60.
Better Therapeutics, Inc. (NASDAQ:BTTX) shares rose 19.1% to close at $7.68 after Chardan Capital initiated coverage on the stock with a Buy rating and a $17 price target.
Augmedix, Inc. (NASDAQ:AUGX) gained 19% to settle at $3.45. Augmedix recently posted a Q3 net loss of $2.859 million.
Ocuphire Pharma, Inc. (NASDAQ:OCUP) gained 18.8% to close at $4.1350 after the company announced that the first subjects have been enrolled in the MIRA-3 Phase 3 pivotal trial evaluating Nyxol Eye Drops in the reversal of pharmacologically-induced mydriasis.
Society Pass Incorporated (NASDAQ:SOPA) jumped 17.8% to settle at $13.17 amid continued volatility following the stock's IPO earlier in the month.
ForgeRock, Inc. (NYSE:FORG) gained 17.6% to close at $29.14. The company recently posted upbeat quarterly results.
MyMD Pharmaceuticals, Inc. (NASDAQ:MYMD) gained 17.2% to close at $7.10. MyMD Pharma Form 4 filing showed the company’s VP of Operations Paul Rivard bought 15,000 shares of co. stock on Nov. 23.
Nxt-ID, Inc. (NASDAQ:NXTD) gained 17% to close at $3.10.
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) jumped 16.9% to settle at $31.50.
Finch Therapeutics Group, Inc. (NASDAQ:FNCH) gained 16.3% to close at $15.74. Finch Therapeutics Group recently announced positive topline results from PRISM-EXT, an open-label extension of the PRISM3 Phase 2 trial evaluating CP101 to prevent recurrent C. difficile infection (CDI).
Global-e Online Ltd. (NASDAQ:GLBE) jumped 15.8% to close at $60.99 after the company announced it will acquire Flow Commerce for an aggregate purchase price of up to approximately $500 million.
Paltalk, Inc. (NASDAQ:PALT) gained 15.7% to close at $4.06.
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) jumped 15.6% to close at $18.80.
Recursion Pharmaceuticals recently reported Q3 earnings results.
Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) gained 15.5% to close at $3.43. Brainstorm Cell recently posted Q3 loss of $0.15 per share.
Guardant Health, Inc. (NASDAQ:GH) gained 15.5% to close at $107.25 following stock purchases by the company's Co-CEOs.
Instil Bio, Inc. (NASDAQ:TIL) gained 14.5% to settle at $19.86
Golden Ocean Group Limited (NASDAQ:GOGL) rose 14.1% to close at $9.12 after reporting Q3 results.
Foghorn Therapeutics Inc. (NASDAQ:FHTX) gained 14.1% to close at $14.21. HC Wainwright & Co. recently initiated coverage on Foghorn Therapeutics with a Buy rating and announced a price target of $25.
Pure Storage, Inc. (NASDAQ:PSTG) climbed 13.5% to settle at $30.95 after the company reported better-than-expected Q3 EPS and sales results and issued Q4 and FY22 sales guidance above estimates.
Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) gained 13.2% to close at $3.85. Reviva Pharmaceuticals recently posted a Q3 loss of $0.12 per share.
BIOLASE, Inc. (NASDAQ:BIOL) rose 11.9% to settle at $0.4700 after Nasdaq granted the company 180-day extension to meet minimum bid price requirement. The company also entered into favorable credit deal.
Guess', Inc. (NYSE:GES) gained 11.4% to close at $23.73 after the company reported better-than-expected Q3 EPS and sales results and raised its quarterly dividend.
Benessere Capital Acquisition Corp. (NASDAQ:BENE) climbed 10.4% to close at $11.23. eCombustible Energy will merge with Benessere Capital Acquisition Corp. in a $805 million deal.
Kidpik Corp. (NASDAQ:PIK) gained 10.3% to close at $6.32. The company recently priced its IPO at $8.50 per share.
HP Inc. (NYSE:HPQ) climbed 10.1% to settle at $35.44 after the company reported better-than-expected results for its fourth quarter and issued strong earnings forecast for the current quarter.
Bridgeline Digital, Inc. (NASDAQ:BLIN) rose 9.4% to close at $3.04.
Meiwu Technology Company Limited (NASDAQ:WNW) shares rose 8.3% to close at $3.38.

Check out these big penny stock gainers and losers

Losers

Qualigen Therapeutics, Inc. (NASDAQ:QLGN) shares fell 31.6% to settle at $1.75 on Wednesday after jumping around 105% on Tuesday.
Aptevo Therapeutics Inc. (NASDAQ:APVO) fell 29.8% to close at $11.95. Aptevo Therapeutics shares climbed 163% on Tuesday after the company announced a clinical update for its Phase 1b Expansion trial evaluating APVO436 in the treatment of AML. Preliminary data observed to date includes one complete remission.
Nordstrom, Inc. (NYSE:JWN) shares fell 29% to close at $22.66 after the company reported worse-than-expected Q3 sales results. Jefferies downgraded Nordstrom from Buy to Hold and lowered the price target from $48 to $30.
Pasithea Therapeutics Corp. (NASDAQ:KTTA) declined 28.8% to close at $3.99. Pasithea Therapeutics priced its 8.68 million share private placement at $3.50 per share.
Vallon Pharmaceuticals, Inc. (NASDAQ:VLON) fell 26.2% to close at $5.39 on Wednesday after jumping over 80% on Tuesday.
The Gap, Inc. (NYSE:GPS) fell 24.1% to close at $17.84 after the company reported worse-than-expected Q3 EPS and sales results and cut FY21 adjusted EPS guidance below estimates.
Esperion Therapeutics, Inc. (NASDAQ:ESPR) shares fell 23.3% to close at $7.69 after surging over 40% on Tuesday.
iSpecimen Inc. (NASDAQ:ISPC) fell 22.7% to close at $10.20. iSpecimen shares jumped over 48% on Tuesday on continued upward momentum after the company announced it has been contracted to support new advanced research on COVID-19 seeking insights on its transmissibility, variants, outcomes, and testing validity among multiple population segments.
Petros Pharmaceuticals, Inc. (NASDAQ:PTPI) fell 21.8% to close at $1.83 after jumping over 75% on Tuesday.
Centogene N.V. (NASDAQ:CNTG) fell 19.2% to close at $7.20. Centogene reported Q3 sales of €30.2 million, down 17% Y/Y, driven by decreasing revenues from COVID-19 testing.
MediciNova, Inc. (NASDAQ:MNOV) shares fell 19.2% to close at $3.57 after surging 44% on Tuesday.
Outlook Therapeutics, Inc. (NASDAQ:OTLK) fell 18.6% to close at $1.27 after the company reported a $10 million bought deal offering of common stock.
TDCX Inc. (NYSE:TDCX) dropped 17.3% to close at $18.72 following Q3 results.
Nuvation Bio Inc. (NYSE:NUVB) fell 16.2% to close at $7.75.
Kura Oncology, Inc. (NASDAQ:KURA) declined 15.5% to close at $14.02 after the company announced the FDA placed the KOMET-001 Phase 1b study of KO-539 in patients with relapsed or refractory acute myeloid leukemia (AML) on a partial clinical hold.
Autodesk, Inc. (NASDAQ:ADSK) shares fell 15.5% to close at $256.90. Autodesk reported upbeat results for its third quarter, but issued disappointing guidance. Autodesk said it sees Q4 revenue of $1.185 billion to $1.2 billion and non-GAAP earnings of $1.41 to $1.47 per share.
Anaplan, Inc. (NYSE:PLAN) shares fell 15.1% to close at $44.22 after the company reported Q3 earnings results. Piper Sandler downgraded Anaplan from Overweight to Neutral and lowered the price target from $77 to $48.
Viomi Technology Co., Ltd (NASDAQ:VIOT) slipped 14% to close at $3.51 following Q3 results.
Eliem Therapeutics, Inc. (NASDAQ:ELYM) declined 12.3% to settle at $15.48
Clarus Therapeutics Holdings, Inc. (NASDAQ:CRXT) shares fell 12% to close at $5.05. Clarus Therapeutics shares jumped 43% on Tuesday after the company was granted a U.S. Patent titled 'Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same.'
Noah Holdings Limited (NYSE:NOAH) dropped 11.4% to close at $39.03 following Q3 results. JP Morgan downgraded Noah Holdings from Overweight to Neutral and announced a $50 price target.
NerdWallet, Inc. (NASDAQ:NRDS) dropped 11.2% to close at $22.59. The company recently priced its IPO at $4 per share.
Gracell Biotechnologies Inc. (NASDAQ:GRCL) fell 9% to close at $7.09. Gracell Biotechnologies shares gained 22% on Tuesday after the company reported members of its senior management team intend to use personal funds to buy up to $2 million in company ADSs in the open market over the next 3 months.
Titan Machinery Inc. (NASDAQ:TITN) declined 8.8% to settle at $34.94. Baird downgraded Titan Machinery from Outperform to Neutral and raised the price target from $37 to $41.
Dillard's, Inc. (NYSE:DDS) fell 7.9% to close at $377.67.
Citi Trends, Inc. (NASDAQ:CTRN) declined 7.9% to settle at $84.01
Abercrombie & Fitch Co. (NYSE:ANF) fell 4.6% to close at $39.25. Abercrombie & Fitch recently reported third-quarter FY21 sales growth of 10% year-on-year, to $905.16 million, beating the analyst consensus of $896.86 million.

Gainers

赢家

AeroClean Technologies, Inc. (NASDAQ:AERC) shares gained 689.4% to settle at $78.94 on Wednesday after the company priced its IPO at $10 per share.
Longeveron Inc. (NASDAQ:LGVN) rose 145.6% to settle at $42.30 on Wednesday after tumbling 39% on Tuesday. The company last week announced the FDA granted Rare Pediatric Disease designation for Lomecel-B for the treatment of Hypoplastic Left Heart Syndrome.
Biofrontera Inc. (NASDAQ:BFRI) shares climbed 98.5% to close $5.22 on Wednesday after Roth Capital initiated coverage on the stock with a Buy rating and a $20 price target.
IM Cannabis Corp. (NASDAQ:IMCC) gained 37.8% to settle at $4.30. IM Cannabis recently announced its unaudited financial results on Monday for the three and nine-month periods ended September 30, 2021, with revenues of CA$14.4 million ($11.5 million), a sequential increase of approximately 30%.
Local Bounti Corporation (NYSE:LOCL) surged 32.6% to close at $10.62.
Blue Star Foods Corp. (NASDAQ:BSFC) gained 29.9% to settle at $3.65. Blue Star Foods recently reported $3.73 million in quarterly sales.
Spark Networks SE (NYSE:LOV) jumped 23.6% to close at $3.30. Spark Networks 10% owner Osmium Diamond Lp acquired a total of 1654197 shares at an average price of $2.51.
Femasys Inc. (NASDAQ:FEMY) gained 22.9% to settle at $4.99. Femasys recently posted Q3 loss of $0.19 per share.
Standard Lithium Ltd. (NYSE:SLI) surged 22.2% to close at $10.63 after the company announced a $100 million direct investment from Koch Strategic Platforms.
Cyclerion Therapeutics, Inc. (NASDAQ:CYCN) gained 22.1% to settle at $2.65.
Trio-Tech International (NYSE:TRT) jumped 21.5% to close at $10.75.
Trio-Tech recently reported Q1 results, posting a 49% year-over-year increase in total revenue.
Grom Social Enterprises, Inc. (NASDAQ:GROM) rose 20.9% to close at $2.72. Grom Social Enterprises disclosed that its newest division, Curiosity Ink Media, unwrapped Santa.com.
Dermata Therapeutics, Inc. (NASDAQ:DRMA) gained 20.6% to settle at $2.81. Dermata Therapeutics recently announced data from its Phase 1b proof of concept study evaluating a single treatment of DMT410 to treat multiple aesthetic skin conditions.
Engine Gaming and Media, Inc. (NASDAQ:GAME) rose 19.8% to close at $3.81 after the company reported Q4 2021 and FY21 revenue was higher year over year.
IDW Media Holdings, Inc. (NYSE:IDW) gained 19.3% to close at $2.60.
Better Therapeutics, Inc. (NASDAQ:BTTX) shares rose 19.1% to close at $7.68 after Chardan Capital initiated coverage on the stock with a Buy rating and a $17 price target.
Augmedix, Inc. (NASDAQ:AUGX) gained 19% to settle at $3.45. Augmedix recently posted a Q3 net loss of $2.859 million.
Ocuphire Pharma, Inc. (NASDAQ:OCUP) gained 18.8% to close at $4.1350 after the company announced that the first subjects have been enrolled in the MIRA-3 Phase 3 pivotal trial evaluating Nyxol Eye Drops in the reversal of pharmacologically-induced mydriasis.
Society Pass Incorporated (NASDAQ:SOPA) jumped 17.8% to settle at $13.17 amid continued volatility following the stock's IPO earlier in the month.
ForgeRock, Inc. (NYSE:FORG) gained 17.6% to close at $29.14. The company recently posted upbeat quarterly results.
MyMD Pharmaceuticals, Inc. (NASDAQ:MYMD) gained 17.2% to close at $7.10. MyMD Pharma Form 4 filing showed the company’s VP of Operations Paul Rivard bought 15,000 shares of co. stock on Nov. 23.
Nxt-ID, Inc. (NASDAQ:NXTD) gained 17% to close at $3.10.
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) jumped 16.9% to settle at $31.50.
Finch Therapeutics Group, Inc. (NASDAQ:FNCH) gained 16.3% to close at $15.74. Finch Therapeutics Group recently announced positive topline results from PRISM-EXT, an open-label extension of the PRISM3 Phase 2 trial evaluating CP101 to prevent recurrent C. difficile infection (CDI).
Global-e Online Ltd. (NASDAQ:GLBE) jumped 15.8% to close at $60.99 after the company announced it will acquire Flow Commerce for an aggregate purchase price of up to approximately $500 million.
Paltalk, Inc. (NASDAQ:PALT) gained 15.7% to close at $4.06.
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) jumped 15.6% to close at $18.80.
Recursion Pharmaceuticals recently reported Q3 earnings results.
Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) gained 15.5% to close at $3.43. Brainstorm Cell recently posted Q3 loss of $0.15 per share.
Guardant Health, Inc. (NASDAQ:GH) gained 15.5% to close at $107.25 following stock purchases by the company's Co-CEOs.
Instil Bio, Inc. (NASDAQ:TIL) gained 14.5% to settle at $19.86
Golden Ocean Group Limited (NASDAQ:GOGL) rose 14.1% to close at $9.12 after reporting Q3 results.
Foghorn Therapeutics Inc. (NASDAQ:FHTX) gained 14.1% to close at $14.21. HC Wainwright & Co. recently initiated coverage on Foghorn Therapeutics with a Buy rating and announced a price target of $25.
Pure Storage, Inc. (NASDAQ:PSTG) climbed 13.5% to settle at $30.95 after the company reported better-than-expected Q3 EPS and sales results and issued Q4 and FY22 sales guidance above estimates.
Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) gained 13.2% to close at $3.85. Reviva Pharmaceuticals recently posted a Q3 loss of $0.12 per share.
BIOLASE, Inc. (NASDAQ:BIOL) rose 11.9% to settle at $0.4700 after Nasdaq granted the company 180-day extension to meet minimum bid price requirement. The company also entered into favorable credit deal.
Guess', Inc. (NYSE:GES) gained 11.4% to close at $23.73 after the company reported better-than-expected Q3 EPS and sales results and raised its quarterly dividend.
Benessere Capital Acquisition Corp. (NASDAQ:BENE) climbed 10.4% to close at $11.23. eCombustible Energy will merge with Benessere Capital Acquisition Corp. in a $805 million deal.
Kidpik Corp. (NASDAQ:PIK) gained 10.3% to close at $6.32. The company recently priced its IPO at $8.50 per share.
HP Inc. (NYSE:HPQ) climbed 10.1% to settle at $35.44 after the company reported better-than-expected results for its fourth quarter and issued strong earnings forecast for the current quarter.
Bridgeline Digital, Inc. (NASDAQ:BLIN) rose 9.4% to close at $3.04.
Meiwu Technology Company Limited (NASDAQ:WNW) shares rose 8.3% to close at $3.38.

AeroClean Technologies，Inc.纳斯达克(Sequoia Capital：AERC)周三股价上涨689.4%，收于78.94美元，此前该公司将首次公开募股价格定为每股10美元。
隆格韦隆公司(Longeveron Inc.)纳斯达克(Sequoia Capital：LGVN)周三上涨145.6%，收于42.3美元，周二暴跌39%.该公司上周宣布，FDA授予Lomecel-B治疗左心发育不良综合征的罕见儿科疾病称号。
Biofrontera Inc.纳斯达克(Standard Chartered Bank：BFRI)股价周三攀升98.5%，收于5.22美元，此前罗斯资本对该股的评级为买入，目标价为20美元。
我是大麻公司。纳斯达克(Sequoia Capital：IMCC)上涨37.8%，收于4.3美元。IM Cannabis最近于周一公布了截至2021年9月30日的三个月和九个月的未经审计的财务业绩，收入为1440万加元(合1150万美元)，环比增长约30%。
当地邦蒂公司(纽约证券交易所代码：Locl)暴涨32.6%，收于10.62美元。
蓝星食品公司(Blue Star Foods Corp.)纳斯达克(Sequoia Capital：BSFC)上涨29.9%，收于3.65美元。蓝星食品(Blue Star Foods)最近公布的季度销售额为373万美元。
星火网络SE(纽约证券交易所股票代码：LOV)跳涨23.6%，收于3.30美元。星火网络10%的持有者欧司曼钻石有限责任公司以2.51%的平均价格收购了总计1654197股。
Femasys Inc.纳斯达克(Weibo：FAMY)上涨22.9%，收于4.99美元。Femasys最近公布第三季度每股亏损0.19美元。
标准锂有限公司(纽约证券交易所代码：SLI)股价飙升22.2%，收于10.63美元，此前该公司宣布从科赫战略平台获得1亿美元的直接投资。
Cyclarie治疗公司(Cyclarion Treateutics，Inc.)纳斯达克(Weibo：CYCN)上涨22.1%，收于2.65美元。
国际三重技术公司(Trio-Tech International)(纽约证券交易所代码：TRT)跳涨21.5%，收报10.75美元。
Trio-Tech最近公布了第一季度业绩，总收入同比增长49%。
格罗姆社会企业公司纳斯达克(Starbucks：Grom)上涨20.9%，收于2.72美元。格罗姆社会企业(Grom Social Enterprise)透露，其最新部门好奇号墨水传媒(Curiity Ink Media)解开了Santa.com。
皮玛塔治疗公司(Dermata Treateutics，Inc.)纳斯达克(Sequoia Capital：DRMA)上涨20.6%，收于2.81美元。皮玛治疗公司最近公布了其1b期概念验证研究的数据，该研究评估了DMT410治疗多种美容皮肤病的单一疗法。
Engine Gaming and Media，Inc.纳斯达克(GAME：GAME)上涨19.8%，收于3.81美元，此前该公司公布2021年第四季度和21财年营收同比增长。
IDW Media Holdings，Inc.(纽约证券交易所代码：IDW)上涨19.3%，收于2.60美元。
Better Treateutics，Inc.纳斯达克(Standard Chardan Capital：BTTX)股价上涨19.1%，收于7.68美元，此前查尔丹资本对该股的评级为买入，目标价为17美元。
Augmedix，Inc.纳斯达克(Sequoia Capital：AUGX)上涨19%，收于3.45美元。Augmedix最近公布第三季度净亏损285.9万美元。
奥克菲尔制药公司(Ocuphire Pharma，Inc.)纳斯达克(Starbucks：OCUP)股价上涨18.8%，收于4.1350美元，此前该公司宣布，首批受试者已参加MIRA-3期3期关键试验，评估尼索尔滴眼液逆转药物性散瞳的作用。
协会通行证有限公司纳斯达克(Sequoia Capital：SOPA)股价上涨17.8%，收于13.17美元，该股本月早些时候上市后持续波动。
ForgeRock，Inc.(纽约证券交易所代码：FORG)上涨17.6%，收于29.14美元。该公司最近公布了乐观的季度业绩。
MyMD制药公司纳斯达克(Sequoia Capital：MYMD)上涨17.2%，收于7.1美元。MyMD Pharma Form 4备案文件显示，该公司运营副总裁保罗·里瓦德购买了15,000股公司股票。11月23日的股票。
NXT-ID，Inc.纳斯达克(Sequoia Capital：NXTD)上涨17%，收于3.1美元。
Rani治疗控股公司纳斯达克(Didi Chuxing：RANI)跳涨16.9%，收于31.5美元。
芬奇治疗集团(Finch Treateutics Group，Inc.)纳斯达克(Sequoia Capital：FNCH)上涨16.3%，收于15.74美元。芬奇治疗集团最近宣布了PRISM-EXT的阳性背线试验结果，PRISM-EXT是PRISM3阶段2试验的开放扩展，评估CP101以防止艰难梭菌感染(CDI)复发。
环球电子在线有限公司纳斯达克(GLBE：GLBE)跳涨15.8%，收报60.99美元，此前该公司宣布将以总计约5亿美元的价格收购Flow Commerce。
PalTalk，Inc.纳斯达克(Didi Chuxing：PALT)上涨15.7%，收于4.06美元。
递归制药公司纳斯达克(Starbucks：RXRX)跳涨15.6%，收于18.8美元。
递归制药公司(Recursion PharmPharmticals)最近公布了第三季度收益业绩。
头脑风暴细胞治疗公司。纳斯达克(Sequoia Capital：BCLI)上涨15.5%，收于3.43美元。头脑风暴细胞最近公布第三季度每股亏损0.15美元。
Guardant Health，Inc.纳斯达克(Sequoia Capital：GH)股价上涨15.5%，收于107.25美元，此前该公司联席首席执行官买入股票。
Instil Bio，Instant，Inc.纳斯达克(TIL：TIL)上涨14.5%，收于19.86美元
金海集团有限公司纳斯达克(GOGL：GOGL)公布第三季度财报后，股价上涨14.1%，收于9.12美元。
福格霍恩治疗公司(Foghorn Treateutics Inc.)纳斯达克(Starbucks：FHTX)上涨14.1%，收于14.21美元。HC Wainwright&Co.最近开始对Foghorn治疗公司进行买入评级，并宣布目标价为25美元。
Pure Storage，Inc.纳斯达克(Sequoia Capital：PSTG)股价上涨13.5%，收于30.95美元，此前该公司公布了好于预期的第三季度每股收益和销售业绩，并发布了高于预期的第四季度和22财年销售指引。
Reviva制药控股公司(Reviva PharmPharmticals Holdings，Inc.)纳斯达克(Sequoia Capital：RVPH)上涨13.2%，收于3.85美元。Reviva PharmPharmticals最近公布第三季度每股亏损0.12美元。
Biolase，Inc.纳斯达克(Sequoia Capital：BIOL)股价上涨11.9%，收于0.4700美元，此前纳斯达克批准该公司延期180天，以满足最低投标价格要求。该公司还达成了优惠的信贷交易。
Guess‘，Inc.(纽约证券交易所代码：GES)股价上涨11.4%，收于23.73美元，此前该公司公布了好于预期的第三季度每股收益和销售业绩，并提高了季度股息。
贝内斯尔资本收购公司纳斯达克(Weibo：Bene)攀升10.4%，收于11.23美元。ECombusable Energy将与Benessere Capital Acquisition Corp.合并，交易金额为8.05亿美元。
基德皮克公司(Kidpik Corp.)纳斯达克(Sequoia Capital：PIK)上涨10.3%，收于6.32美元。该公司最近将首次公开募股(IPO)定价为每股8.50美元。
惠普公司惠普(NYSE：HPQ)股价攀升10.1%，收于35.44美元，此前该公司公布了好于预期的第四季度业绩，并发布了强劲的当前季度收益预期。
Bridgeline Digital，Inc.纳斯达克(Sequoia Capital：BLIN)上涨9.4%，收于3.04美元。
美物科技有限公司纳斯达克(Sequoia Capital：WNW)股价上涨8.3%，收于3.38美元。

Check out these big penny stock gainers and losers

看看这些微不足道的股票赢家和输家

Losers

失败者

Qualigen Therapeutics, Inc. (NASDAQ:QLGN) shares fell 31.6% to settle at $1.75 on Wednesday after jumping around 105% on Tuesday.
Aptevo Therapeutics Inc. (NASDAQ:APVO) fell 29.8% to close at $11.95. Aptevo Therapeutics shares climbed 163% on Tuesday after the company announced a clinical update for its Phase 1b Expansion trial evaluating APVO436 in the treatment of AML. Preliminary data observed to date includes one complete remission.
Nordstrom, Inc. (NYSE:JWN) shares fell 29% to close at $22.66 after the company reported worse-than-expected Q3 sales results. Jefferies downgraded Nordstrom from Buy to Hold and lowered the price target from $48 to $30.
Pasithea Therapeutics Corp. (NASDAQ:KTTA) declined 28.8% to close at $3.99. Pasithea Therapeutics priced its 8.68 million share private placement at $3.50 per share.
Vallon Pharmaceuticals, Inc. (NASDAQ:VLON) fell 26.2% to close at $5.39 on Wednesday after jumping over 80% on Tuesday.
The Gap, Inc. (NYSE:GPS) fell 24.1% to close at $17.84 after the company reported worse-than-expected Q3 EPS and sales results and cut FY21 adjusted EPS guidance below estimates.
Esperion Therapeutics, Inc. (NASDAQ:ESPR) shares fell 23.3% to close at $7.69 after surging over 40% on Tuesday.
iSpecimen Inc. (NASDAQ:ISPC) fell 22.7% to close at $10.20. iSpecimen shares jumped over 48% on Tuesday on continued upward momentum after the company announced it has been contracted to support new advanced research on COVID-19 seeking insights on its transmissibility, variants, outcomes, and testing validity among multiple population segments.
Petros Pharmaceuticals, Inc. (NASDAQ:PTPI) fell 21.8% to close at $1.83 after jumping over 75% on Tuesday.
Centogene N.V. (NASDAQ:CNTG) fell 19.2% to close at $7.20. Centogene reported Q3 sales of €30.2 million, down 17% Y/Y, driven by decreasing revenues from COVID-19 testing.
MediciNova, Inc. (NASDAQ:MNOV) shares fell 19.2% to close at $3.57 after surging 44% on Tuesday.
Outlook Therapeutics, Inc. (NASDAQ:OTLK) fell 18.6% to close at $1.27 after the company reported a $10 million bought deal offering of common stock.
TDCX Inc. (NYSE:TDCX) dropped 17.3% to close at $18.72 following Q3 results.
Nuvation Bio Inc. (NYSE:NUVB) fell 16.2% to close at $7.75.
Kura Oncology, Inc. (NASDAQ:KURA) declined 15.5% to close at $14.02 after the company announced the FDA placed the KOMET-001 Phase 1b study of KO-539 in patients with relapsed or refractory acute myeloid leukemia (AML) on a partial clinical hold.
Autodesk, Inc. (NASDAQ:ADSK) shares fell 15.5% to close at $256.90. Autodesk reported upbeat results for its third quarter, but issued disappointing guidance. Autodesk said it sees Q4 revenue of $1.185 billion to $1.2 billion and non-GAAP earnings of $1.41 to $1.47 per share.
Anaplan, Inc. (NYSE:PLAN) shares fell 15.1% to close at $44.22 after the company reported Q3 earnings results. Piper Sandler downgraded Anaplan from Overweight to Neutral and lowered the price target from $77 to $48.
Viomi Technology Co., Ltd (NASDAQ:VIOT) slipped 14% to close at $3.51 following Q3 results.
Eliem Therapeutics, Inc. (NASDAQ:ELYM) declined 12.3% to settle at $15.48
Clarus Therapeutics Holdings, Inc. (NASDAQ:CRXT) shares fell 12% to close at $5.05. Clarus Therapeutics shares jumped 43% on Tuesday after the company was granted a U.S. Patent titled 'Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same.'
Noah Holdings Limited (NYSE:NOAH) dropped 11.4% to close at $39.03 following Q3 results. JP Morgan downgraded Noah Holdings from Overweight to Neutral and announced a $50 price target.
NerdWallet, Inc. (NASDAQ:NRDS) dropped 11.2% to close at $22.59. The company recently priced its IPO at $4 per share.
Gracell Biotechnologies Inc. (NASDAQ:GRCL) fell 9% to close at $7.09. Gracell Biotechnologies shares gained 22% on Tuesday after the company reported members of its senior management team intend to use personal funds to buy up to $2 million in company ADSs in the open market over the next 3 months.
Titan Machinery Inc. (NASDAQ:TITN) declined 8.8% to settle at $34.94. Baird downgraded Titan Machinery from Outperform to Neutral and raised the price target from $37 to $41.
Dillard's, Inc. (NYSE:DDS) fell 7.9% to close at $377.67.
Citi Trends, Inc. (NASDAQ:CTRN) declined 7.9% to settle at $84.01
Abercrombie & Fitch Co. (NYSE:ANF) fell 4.6% to close at $39.25. Abercrombie & Fitch recently reported third-quarter FY21 sales growth of 10% year-on-year, to $905.16 million, beating the analyst consensus of $896.86 million.

夸里根治疗公司(Qualigen Treateutics，Inc.)纳斯达克(Starbucks：QLGN)股价周三下跌31.6%，收于1.75美元，周二大涨约105%。
Aptevo治疗公司纳斯达克(APVO：APVO)跌29.8%，收报11.95美元。Aptevo治疗公司股价周二上涨163%，此前该公司宣布了评估APVO436治疗AML的1b期扩大试验的临床更新。到目前为止观察到的初步数据包括一次完全缓解。
诺德斯特龙公司(纽约证券交易所代码：JWN)股价下跌29%，收于22.66美元，此前该公司公布的第三季度销售业绩逊于预期。Jefferies将诺德斯特龙的评级从买入下调至持有，并将目标价从48美元下调至30美元。
帕西娅治疗公司(Pasithea Treateutics Corp.)纳斯达克(KTTA：KTTA)下跌28.8%，收于3.99美元。帕西娅治疗公司(Pasithea Treeutics)将其868万股私募定价为每股3.50美元。
瓦隆制药公司纳斯达克(Sequoia Capital：VLON)周三下跌26.2%，收于5.39美元，周二曾跃升逾80%。
The Gap，Inc.(纽约证券交易所股票代码：GPS)下跌24.1%，收于17.84美元，此前该公司公布的第三季度每股收益和销售业绩逊于预期，并将21财年调整后每股收益指引下调至低于预期。
Esperion治疗公司纳斯达克(Sequoia Capital：ESPR)股价周二飙升逾40%后，下跌23.3%，收于7.69美元。
ISpecimen Inc.纳斯达克(Sequoia Capital：ISPC)下跌22.7%，收于10.20美元。在宣布签约支持新冠肺炎新的高级研究后，iSpecimen的股价周二上涨超过48%，该公司宣布已经签约支持微博的新的高级研究，寻求对微博的传播性、变种、结果和在多个人群中测试有效性的见解。
Petros制药公司纳斯达克(Starbucks：PTPI)周二跳涨逾75%后下跌21.8%，收报1.83美元。
新泽西州森特吉纳斯达克(Standard Chartered Bank：CNTG)下跌19.2%，收于7.2美元。Centogene报告第三季度销售额为3020万欧元，同比下降17%，原因是新冠肺炎测试收入下降。
MediciNova，Inc.纳斯达克(Sequoia Capital：MNOV)股价周二大涨44%后，下跌19.2%，收于3.57美元。
Outlook治疗公司纳斯达克(Starbucks：OTLK)股价下跌18.6%，收于1.27美元，此前该公司公布以1,000万美元买入普通股。
TDCX Inc.(纽约证券交易所代码：TDCX)在第三季度业绩公布后下跌17.3%，收于18.72美元。
Nuvation Bio Inc.(纽约证券交易所代码：NUVB)下跌16.2%，收于7.75美元。
库拉肿瘤公司纳斯达克(KURA)股价下跌15.5%，收于14.02美元，此前该公司宣布美国食品和药物管理局(FDA)将KO-539在复发或难治性急性髓细胞白血病(AML)患者中的KOMET-001b期研究部分临床搁置。
欧特克公司纳斯达克(Sequoia Capital：ADSK)股价下跌15.5%，收于256.90美元。欧特克公布了乐观的第三季度业绩，但发布了令人失望的指引。欧特克表示，预计第四季度营收为11.85亿至12亿美元，非GAAP每股收益为1.41至1.47美元。
Anaplan，Inc.(纽约证券交易所股票代码：PLAN)股价下跌15.1%，收于44.22美元，此前该公司公布了第三季度收益业绩。Piper Sandler将Anaplan评级从加码下调至中性，目标价从77美元下调至48美元。
云米科技股份有限公司纳斯达克(Sequoia Capital：VIOT)第三季度财报公布后，股价下跌14%，收于3.51美元。
埃利姆治疗公司纳斯达克(Sequoia Capital：ELYM)下跌12.3%，收于15.48美元
克拉鲁斯治疗控股公司(Clarus Treateutics Holdings，Inc.)纳斯达克(Starbucks：CRXT)股价下跌12%，收于5.05美元。克拉鲁斯治疗公司(Clarus Treeutics)周二股价上涨43%，此前该公司获得了一项名为“口服睾酮酯配方和治疗睾酮缺乏症的方法”的美国专利。
诺亚财富有限公司(纽约证券交易所股票代码：NOAH)第三季度财报公布后，该公司股价下跌11.4%，收于39.03美元。(投行观点)摩根大通将诺亚财富评级从加码下调至中性，并宣布目标价为50美元
NerdWallet，Inc.纳斯达克(Starbucks：NRDS)下跌11.2%，收于22.59美元。该公司最近将首次公开募股(IPO)定价为每股4美元。
亘喜生物(Sequoia Capital Inc.)纳斯达克(GRCL：GRCL)下跌9%，收于7.09美元。亘喜生物周二股价上涨22%，此前该公司报道称，其高级管理团队成员打算在未来3个月内利用个人资金在公开市场购买高达200万美元的公司美国存托凭证。
泰坦机械公司纳斯达克(Starbucks：TITN)下跌8.8%，收于34.94美元。Baird将泰坦机械评级从跑赢大盘下调至中性，并将目标价从37美元上调至41美元。
迪拉德公司(Dillard‘s，Inc.)(纽约证券交易所代码：DDS)下跌7.9%，收于377.67美元。
花旗趋势公司(Citi Trends，Inc.)纳斯达克(Sequoia Capital：CTRN)下跌7.9%，收于84.01美元
Abercrombie&Fitch Co.(纽约证券交易所代码：ANF)下跌4.6%，收于39.25美元。Abercrombie&Fitch最近公布，2011财年第三季度销售额同比增长10%，至9.0516亿美元，超出分析师一致预期的8.9686亿美元。

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。更多信息

68 Biggest Movers From Wednesday

68 Biggest Movers From Wednesday

Gainers

Losers

Gainers

赢家

Losers

失败者

风险及免责提示

声明